1. Home
  2. HTZ vs IMNM Comparison

HTZ vs IMNM Comparison

Compare HTZ & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hertz Global Holdings Inc

HTZ

Hertz Global Holdings Inc

HOLD

Current Price

$5.46

Market Cap

1.6B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.71

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTZ
IMNM
Founded
1918
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
HTZ
IMNM
Price
$5.46
$20.71
Analyst Decision
Hold
Strong Buy
Analyst Count
4
9
Target Price
$5.05
$26.89
AVG Volume (30 Days)
8.5M
1.2M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,516,000,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.15
$5.15
52 Week High
$9.39
$20.46

Technical Indicators

Market Signals
Indicator
HTZ
IMNM
Relative Strength Index (RSI) 52.29 65.02
Support Level $5.03 $18.87
Resistance Level $5.68 $20.46
Average True Range (ATR) 0.25 1.22
MACD 0.05 0.08
Stochastic Oscillator 79.20 95.49

Price Performance

Historical Comparison
HTZ
IMNM

About HTZ Hertz Global Holdings Inc

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean. The Company maintain a substantial network of company-operated rental locations, a majority of which are in Europe, and have franchisees and partners that operate rental locations under brands. Geographical markets includes U.S., Europe, Pacific Asia, Middle East and Africa, Latin America.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: